First available
Smart MDI system^ 1,2
Automatically matches CGM & insulin dosing so you don't have to
First available
Staying ahead of glucose levels with our first available Smart MDI system^ 1,2
What is a Smart MDI System^?
The Smart MDI system^ combines the power of our latest innovation in continuous glucose monitoring (CGM), Guardian™ 4 Smart* CGM system with the InPen™ Smart** Insulin Pen System.
The InPen™ system is designed to assist with tracking of insulin doses and dose calculations.
Guardian™ 4 CGM system tracks your patients glucose levels 24/7 every 5 minutes, whilst the InPen™ system helps them take the right insulin dose at the right time.
Combining the power of real time glucose readings with predictive alerts and personalised insulin dosing* to help your patients stay ahead of their glucose levels1,2. Smart MDI systems can help to improve their Time in Range3 (TIR).
InPen™ Smart* insulin pen system
The InPen™ system tracks active insulin, logs dose activity and can help your patients to take the right dose at the right time.
Guardian™ 4 system
Guardian™ 4 Sensor can be worn for up to 7 days and records glucose levels automatically every 5 minutes, 24/7 without calibrations**.
Smart MDI system^
Know before you go low or high with real-time blood glucose readings, trends and alerts.
Guardian™ 4 System training videos
Chapter 1: Getting ready to go with the Guardian™ 4 system
Chapter 2: Inserting the sensor with the Guardian™ 4 System
Chapter 3: Connecting with care partners with the Guardian™ 4 system
Frequently asked questions
The Smart MDI System brings together an ecosystem of smart tools that provide real-time insights and comprehensive reports to make it easier to manage life on MDI.
- The Guardian™ 4 system is a real-time, Continuous Glucose Monitoring (CGM) system indicated for the management of diabetes in persons aged 7 years and older.
- The InPen™ system is intended for single-patient use by people with diabetes for the self-injection of a desired dose of insulin. For patients who do not self-manage their diabetes, the use of InPen™ should always be under the supervision of a caregiver.
We’ve updated our standalone CGM system app and hardware to improve the customer experience. These are the most significant updates that can be found in the Guardian™ 4 system:
- The previous system was called the Guardian™ Connect system. This next generation of our Smart CGM is called the Guardian™ 4 Smart* CGM System
- The Guardian™ 4 system now requires no calibrations**
- Non-adjunctive labeling. This means a user can now make treatment decisions based on the glucose value shown by the system, without the need for a confirmatory finger prick.
*Smart CGM predicts future high and low sensor glucose events up to 1 hour in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns. Please refer to IFU.
** If sensor glucose (SG) values do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide.
At this time, InPen™ system is compatible with Novo Nordisk NovoRapid®, Novo Nordisk Fiasp® and Novo Nordisk Insulin Aspart Injection, 3mL cartridges (300 units).
Blue InPen™ compatible with Novo Nordisk insulin cartridges
The Guardian™ 4 system and InPen™ system apps have a wide range of compatibility with several Apple® and Android™ devices. You can find updated compatibility information here on our website. We recommend checking compatibility and switching off automatic operating system updates to ensure the best possible user experience.
InPen™ system is the first available Smart* insulin pen that uses Bluetooth® technology and intelligence through an easy-to-use Smartphone app to help people administer correction and meal-time insulin doses.
*Smart insulin pen connects to a mobile app to provide dosing calculations, reminders and CGM system integration. Please refer to IFU.
Resources can be found at the My Learning page.
Yes, multiple InPen™ Smart insulin pens can be synced with one app account.
Cartridges are not included with InPen™ system.
ALWAYS FOLLOW THE DIRECTIONS FOR USE.
The Guardian 4 sensor is intended for use with the Guardian 4 transmitter to monitor glucose levels in persons with diabetes where self-monitoring of blood glucose (SMBG) is indicated. The sensor is designed to replace fingerstick blood glucose (BG)readings for diabetes treatment decisions. The sensor is intended for insertion into persons ages 7 years and older. The sensor is intended for insertion into the back of the upper arm or the upper buttocks in persons ages 7 through 17 years. The sensor is intended for insertion into the back of the upper arm or the abdomen in persons ages 18 years and older.
1. Abraham SB, et al. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts. Journal of Diabetes Science and Technology 2021; 15(1):91–97
2. Smith M, et al, E5 , SIPs Improve Time Below Range in MDI Therapy, AMCP Congress 2020
3. Adolfsson P, Væver Hartvig, Kaas A, Møller JB, Hellman J. Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen. Diabetes Technology & Therapeutics, 2020;22(7):online ahead of print
4. Dicimbrini I et al, Effects of real time continuous glucose monitoring in type 1 diabetes : a meta analysis of randomized controlled trials, Acta Diabetologica 2020 doi: 10.1007/s00592-020-01589-3
^Components sold separately
* Smart CGM predicts future high and low sensor glucose events up to 1 hour in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns. Please refer to IFU.
** If sensor glucose (SG) values do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide.
©2023 Medtronic Australasia Pty Ltd. All rights reserved. 2 Alma Road, Macquarie Park, NSW 2113. SpringCM Approval#13032-082023